Pacira | PCRX - Fremdkapital





Fremdkapital Veränderung Datum
Assertio Holdings USD 39.17M 120K 2025-09
Astellas Pharma JPY 320B 0 2026-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Cara Therapeutics USD 0 0 2025-03
Coherus Biosciences USD 51.08M 496K 2025-12
Heron Therapeutics USD 140.64M 975K 2025-12
Ironwood Pharmaceuticals USD 583.99M 14.83M 2024-12
J&J USD 37.53B 1.91B 2026-03
Ligand Pharmaceuticals USD 446.19M 702K 2025-12
Nektar Therapeutics USD 63.16M 44.35M 2025-12
Novo Nordisk DKK 119.17B 231M 2026-03
Omeros USD 403.72M 27.2M 2024-06
Pacira USD 367.66M 4.53M 2026-03
Perrigo USD 3.62B 17.5M 2026-03
Pfizer USD 60.57B 1.08B 2026-03
Supernus Pharmaceuticals USD 400.38M 21.13M 2022-03
Teva Pharmaceutical Industries USD 14.02B 971M 2026-03
Xeris Pharmaceuticals USD 221.22M 889K 2026-03
Xoma USD 94.38M 7.82M 2025-09
Zoetis USD 9.04B 3M 2026-03